US TRT Prescriptions Jump 27% as Men Aged 35-44 Drive 58% Surge
Updated
Updated · WBAL TV Baltimore · Sep 8
US TRT Prescriptions Jump 27% as Men Aged 35-44 Drive 58% Surge
1 articles · Updated · WBAL TV Baltimore · Sep 8
Summary
A recent analysis found U.S. testosterone replacement therapy prescriptions rose 27% from 2018 to 2022, with the sharpest increase in men aged 35-44.
New research easing fears about cardiovascular and prostate risks, plus telehealth marketing and celebrity promotion, helped push testosterone into the mainstream.
Men's Health said its survey of 2,200 American men showed 70% consider testosterone levels important, 40% more than a year ago, and 49% link them to masculinity.
Clinicians say TRT is not a simple low-blood-test decision and should account for symptoms, medications, medical history, family risks and lifestyle.
The rise reflects a broader self-optimization culture as men seek relief from fatigue, low libido, weight gain, sleep problems and loss of focus.